Current Report Filing (8-k)
January 09 2017 - 8:23AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): January 9, 2017
ASSEMBLY BIOSCIENCES, INC.
(Exact name of Registrant as Specified
in Its Charter)
Delaware
|
|
001-35005
|
|
20-8729264
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer Identification No.)
|
11711 N. Meridian Street, Suite 310
Carmel, Indiana 46032
(Address of principal executive offices,
including zip code)
(317) 975-2694
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01. Regulation FD Disclosure
Assembly Biosciences, Inc. (the “Company”)
is furnishing a corporate presentation, attached as Exhibit 99.1 to this Current Report on Form 8-K, which the Company intends
to use from time to time in meetings with investors and others beginning on January 9, 2017. The corporate presentation will also
be available on the Company’s website at http://investor.assemblybio.com/index.cfm.
The information in this Item 7.01 and Exhibit
99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits:
The following exhibit
relating to Item 7.01 shall be deemed furnished, and not filed:
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Assembly Biosciences, Inc. Corporate Presentation January 2017.
|
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
Assembly Biosciences, Inc.
|
|
|
|
By:
|
|
/s/ Derek Small
|
|
|
Derek Small
|
|
|
President and Chief Executive Officer
|
Date: January 9, 2017
EXHIBIT INDEX
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Assembly Biosciences, Inc. Corporate Presentation January 2017.
|
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Apr 2023 to Apr 2024